Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Long Hold Up Anticipated In Council of EU As Member States Battle Over HTA Proposal

Executive Summary

Highly divergent views among member states on the European Commission's proposal for a Health Technology Assessment Regulation are likely to lead to delays as ministers struggle to agree on a revised text.

You may also be interested in...



Medtech Makes Headway In EU HTA Debate, But More Concessions Sought

The European Parliament adopted legislation that would establish an EU-wide system for joint clinical health technology assessments including amendments supported by the device industry. But companies are looking to make the plan less prescriptive when it moves to the EU Council.

HTA Cooperation: European Parliament Gets Ready To Placate Council

The European Parliament’s ENVI committee wants to help the European Council to progress with its work on the European Commission’s proposals on HTA cooperation by assuaging concerns of the EU member states.

Q&A: EU Medtech Industry Joins Growing Opposition To HTA Regulation Proposal

The European Commission's landmark proposal on health technology assessment regulation is meeting with a growing force of opposition. MedTech Europe’s Yves Verboven believes there are better solutions.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122883

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel